Iroko, Calox de Costa Rica deal

Iroko’s Iroko Pharmaceuticals Inc. affiliate granted Calox exclusive rights in Colombia, Costa Rica, Dominican Republic, El Salvador, Guatemala, Nicaragua, Honduras, Panama and Venezuela to develop and commercialize pain product Zorvolex submicron diclofenac. Calox will be responsible for regulatory and pricing approval, as well as marketing and supply of the product. ...